Wendy M. Book

Wendy M. Book

Auto-generated profile, based on publicly available information

Wendy M. Book

Emory University School of Medicine, United States

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2016 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
WBWendy M. Book
Wendy M. Book
JGJennifer Gerardin
Jennifer Gerardin
ASAnita Saraf
Anita Saraf
AVAnne Marie Valente
Anne Marie Valente
FRFred Rodriguez
Fred Rodriguez
Fontan failure has been variably and inconsistently described in the literature, leading to challenges in comparing studies and evaluating treatments. Development of a conceptual framework to describe clinical phenotypes will aid in consistent terminology in the literature. In the heart failure literature, several key concepts have been described-"heart failure" is a clinical syndrome of various etiologies, with phenotype-specific response to therapies. As the congenital heart disease community struggles to grapple with "Fontan failure," these concepts come to light. Fontan failure in the context of four clinical phenotypes, including evaluation, potential management strategies, and future directions is discussed.

17 August 2014 in Congenital Heart Disease
Verified
Journal Article
Open access
PDF file
RERobert W. Elder
Robert W. Elder
NMNancy M. McCabe
Nancy M. McCabe
EVEmir Veledar
Emir Veledar
BKBrian E. Kogon
Brian E. Kogon
MJMaan Jokhadar
Maan Jokhadar
WBWendy M. Book
Wendy M. Book
Objective Risk factors for major adverse events late after Fontan palliation are unknown. Prior studies have suggested ventricular function and morphology as important risk factors. The aim of this study is to (1) characterize the late major adverse event profile in adult Fontan patients and (2) identify additional risk factors that may contribute to adverse outcomes. Design and Setting A retrospective review of all adult patients >15 years post‐Fontan seen at a tertiary academic center was conducted. Clinical, laboratory, cardiac data, and abdominal imaging were collected via chart review. Major adverse events (death, cardiac transplantation, or listing) were identified, and timing of events was plotted using Kaplan–Meier methods. Univariate and multivariate logistic regression was used to determine independent predictors of late‐term events. Results A total of 123 adult Fontan patients were identified (mean time post‐Fontan 22.4 years [±4.4]). Major adverse events occurred in 19/123 patients (15%). In this 15‐year survivor cohort, transplant‐free survival rates were 94.6%, 82.9%, and 59.8% at 20, 25, and 30 years postoperation, respectively. Modes of death were Fontan failure with preserved function (4), congestive heart failure with decreased function (2), sudden death (2), thromboembolic event (1), post‐Fontan conversion (2), and posttransplant (2). No differences in adverse outcomes were found based on morphology of the systemic ventricle, Fontan type, or systolic ventricular function. On the other hand, features of portal hypertension (OR 19.0, CI 4.7–77.3, P < .0001), presence of a pacemaker (OR 13.4, CI 2.6–69.8, P = .002), and systemic oxygen desaturation (OR 0.86, CI 0.75–0.98, P = .02) were risk factors for major adverse events in the multivariate analysis. Conclusions In adult Fontan patients surviving >15 years post‐Fontan, portal hypertension, oxygen desaturation, and need for pacemaker were predictive of adverse events. Traditional measures may not predict late‐term outcomes in adult survivors; further study of the liver's role in late outcomes is warranted.

15 February 2014 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MMMakoto Mori
Makoto Mori
AAAlfredo J. Aguirre
Alfredo J. Aguirre
RERobert W. Elder
Robert W. Elder
AKAli Kashkouli
Ali Kashkouli
AFAlton Brad Farris
Alton Brad Farris
WBWendy M. Book
Wendy M. Book

2 March 2016 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
MMMakoto Mori
Makoto Mori
CHCamden Hebson
Camden Hebson
KSKayoko Shioda
Kayoko Shioda
RERobert W. Elder
Robert W. Elder
BKBrian E. Kogon
Brian E. Kogon
WBWendy M. Book
Wendy M. Book
In heart failure, a high systemic vascular resistance index (SVRI), high central venous pressure (CVP), and low cardiac index (CI) predict poor outcomes. Conversely, late hemodynamic manifestations of failing Fontan circulation and associations with end-organ dysfunction are not well understood. A retrospective review of right-heart catheterization data of adult Fontan patients between 2002 and 2014 was conducted. Relationships between hemodynamic variables and serious adverse events (death or heart transplant) were examined using the Cox proportional hazard analysis. Correlations between the hemodynamic measurements and signs of end-organ dysfunction (MELD-XI, Child-Pugh, VAST score, estimated glomerular filtration rate [eGFR]) were analyzed. Sixty post-Fontan patients (85% systemic left ventricle, 40% atriopulmonary Fontan, mean age of 28 years, and mean time since Fontan operation of 21.9 years) were included. At baseline, those with an event were statistically younger, had lower transcutaneous oxygen saturations, were more likely to have an atriopulmonary Fontan, and were more likely to have a pacemaker. Eighteen experienced a cardiovascularly significant event. Using univariate analysis to compare the event and nonevent groups, mean CI was 2.8 ± 0.9 vs. 2.4 ± 0.5 L/min/m2 (P = .004), and CVP was 18.6 ± 6.5 vs. 16.1 ± 4.3 mmHg (P = .03). However, the statistical significances did not persist in the multivariate model. Higher CVP and pulmonary capillary wedge pressure (PCWP) were associated with higher MELD-XI and Child-Pugh scores, and the VAST score was only associated with PCWP. Symptomatic adult Fontan patients who experienced an event manifested with a higher CI and CVP, although the multivariate Cox proportional hazard analysis did not yield any significant associations. The presences of hepatic dysfunction and portal venous outflow obstruction were associated with a higher CVP and PCWP. Renal dysfunction was prevalent but no statistically significant association between the hemodynamic measurements was identified, although trends toward a higher CVP and transpulmonary gradient were identified.

1 May 2017 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
IEIan K. Everitt
Ian K. Everitt
JGJennifer F. Gerardin
Jennifer F. Gerardin
FRFred H. Rodriguez
Fred H. Rodriguez
WBWendy M. Book
Wendy M. Book
The transition and transfer from pediatric to adult care is becoming increasingly important as improvements in the diagnosis and management of congenital heart disease allow patients to live longer. Transition is a complex and continuous process that requires careful planning. Inadequate transition has adverse effects on patients, their families and healthcare delivery systems. Currently, significant gaps exist in patient care as adolescents transfer to adult care and there are little data to drive the informed management of transition and transfer of care in adolescent congenital heart disease patients. Appropriate congenital heart disease care has been shown to decrease mortality in the adult population. This paper reviews the transition and transfer of care processes and outlines current congenital heart disease specific guidelines in the United States and compares these recommendations to Canadian and European guidelines. It then reviews perceived and real barriers to successful transition and identifies predictors of success during transfer to adult congenital heart disease care. Lastly, it explores how disease-specific markers of outcomes and quality indicators are being utilized to guide transition and transfer of care in other chronic childhood illnesses, and identifies existing knowledge gaps and structural impediments to improving the management of transition and transfer among congenital heart disease patients.

28 April 2015 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
RERobert W. Elder
Robert W. Elder
RGRoshan P. George
Roshan P. George
NMNancy M. McCabe
Nancy M. McCabe
FIFred H. Rodriguez Iii
Fred H. Rodriguez Iii
WBWendy M. Book
Wendy M. Book
AKAllan D. Kirk
Allan D. Kirk
Thymectomy is performed routinely in infants undergoing cardiothoracic surgery. Children post-sternotomy have decreased numbers of T lymphocytes, although the mechanisms involved and long-term consequences of this have not been defined. We hypothesized that lymphopenia in patients with adult congenital heart disease (ACHD) would be reflective of premature T cell maturation and exhaustion. Adults with ACHD who had sternotomy to repair congenital heart disease as infants (<1 year) and age-matched ACHD patients without prior sternotomy were studied using polychromatic flow cytometry interrogating markers of lymphocyte maturation, exhaustion and senescence. Group differences were analyzed using Mann–Whitney U and Fisher’s exact tests. Eighteen ACHD patients aged 21–40 years participated: 10 cases and 8 controls. Median age at sternotomy for cases was 52 days. Cases and controls were matched for age (28.9 vs. 29.1 years; p = 0.83), gender (p = 0.15) and race (p = 0.62) and had similar case complexity. Cases had a lower mean percentage of cytotoxic CD8 lymphocytes compared to controls (26.8 vs. 33.9 %; p = 0.016), with fewer naive, undifferentiated CD8 T cells (31.0 vs. 53.6 %; p = 0.027). CD8 cells expressing PD1, a marker of immune exhaustion, trended higher in cases versus controls (25.6 vs. 19.0 %; p = 0.083). Mean percentage of CD4 cells was higher in cases versus controls (65.6 vs. 59.6 %; p = 0.027), without differences in CD4 T cell maturation subtype. In summary, ACHD patients who undergo sternotomy as infants exhibit differences in T lymphocyte composition compared to ACHD controls, suggesting accelerated immunologic exhaustion. Investigation is warranted to assess the progressive nature and clinical impact of this immune phenotypic change.